Press Releases


Latest News


Adamas Appoints New Chief Financial Officer
Jun 28, 2017 | General Releases

Adamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA Neurology
Jun 12, 2017 | General Releases

Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study Showing Tolerability and Durability out to 88 Weeks
Jun 8, 2017 | General Releases

Adamas to Present at Two Upcoming Investor Conferences
Jun 1, 2017 | General Releases

Adamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in Epilepsy
May 22, 2017 | General Releases

Adamas Signs $100 Million Royalty-Backed Note Agreement with HealthCare Royalty Partners
May 11, 2017 | General Releases

Adamas Reports Recent Achievements and First Quarter 2017 Financial Results
May 9, 2017 | Financial Releases

Adamas Reports Inducement Grant to New Chief Operating Officer
May 5, 2017 | General Releases

Adamas to Announce First Quarter 2017 Financial Results and Host Conference Call on May 9, 2017
May 2, 2017 | General Releases

Adamas Appoints Richard A. King as Chief Operating Officer to Lead Commercialization of ADS-5102
Apr 27, 2017 | General Releases

Pages:  1 2 3 4 5 6 7 8 9 10 11